| Gupta, Gaurav |
NCT06001320: De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients |
|
|
| Recruiting | 4 | 60 | US | Letermovir 480 mg once daily, Historical/Control | Virginia Commonwealth University, Merck Sharp & Dohme LLC | Kidney Transplant; Complications, CMV | 09/25 | 09/26 | | |
FREEDOM-1, NCT03995901: A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation |
|
|
| Terminated | 3 | 15 | US | FCR001, Cell based therapy, Allogeneic stem cell transplant | Talaris Therapeutics Inc. | Transplanted Organ Rejection | 02/23 | 02/23 | | |
| Recruiting | 3 | 50 | Europe, Japan, US, RoW | Iptacopan, LNP023 | Novartis Pharmaceuticals, Novartis Pharma AG | Atypical Hemolytic Uremic Syndrome | 12/25 | 01/26 | | |
Shamrock, NCT06503731: A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients with Antibody-Mediated Rejection (AMR) |
|
|
| Recruiting | 2 | 30 | Europe, Canada, US | Efgartigimod PH20 SC - prefilled syringe, Placebo PH20 SC - prefilled syringe | argenx | Antibody-mediated Rejection | 09/27 | 09/27 | | |
NCT06696131: Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage(ICH) |
|
|
| Not yet recruiting | 1 | 5 | NA | TNK | Gaurav Gupta, MD | Intracerebral Hemorrhage, Intracranial Hemorrhages, Hemorrhagic Strokes | 01/27 | 12/27 | | |
| Suspended | N/A | 193 | Canada | Adverse Childhood Events | Canadian Forces Health Services Centre Ottawa | Chronic Pain | 12/22 | 01/25 | | |
| Recruiting | N/A | 20 | Canada | ERP Testing | Canadian Forces Health Services Centre Ottawa | Brain Concussion | 08/25 | 12/26 | | |
NCT05283070: Correlating Heart Rate Variability and Chronic Pain |
|
|
| Recruiting | N/A | 150 | Canada | Questionnaires, physical tests, and heart rate variability measures | Canadian Forces Health Services Centre Ottawa | Chronic Pain | 12/23 | 06/24 | | |
NCT06538961: Immune Registry for BK in Kidney Transplant Recipients |
|
|
| Recruiting | N/A | 40 | US | Collection of blood samples, Data Collection, Urine Sample | Virginia Commonwealth University, Eurofins | BK Virus Infection, Kidney Transplant; Complications | 05/26 | 05/26 | | |
NCT01299168: Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation |
|
|
| Recruiting | N/A | 500 | Europe, Canada, US, RoW | | University of Alberta | Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards | 12/25 | 06/26 | | |
| Recruiting | N/A | 300 | Europe, Canada, US, RoW | MMDx, Prospera, transplant patient blood sample, HLA antibody | University of Alberta, Natera, Inc., One Lambda | Kidney Transplant Rejection | 12/25 | 12/26 | | |
| Recruiting | N/A | 30 | Canada | Autoinjector, Standard Injector, Prefilled | Canadian Forces Health Services Centre Ottawa | Overdose Antidote, Bleeding, Allergic Reaction | 12/24 | 01/25 | | |
| Suspended | N/A | 400 | Canada | Genetic test for drug response prediction | Canadian Forces Health Services Centre Ottawa | Chronic Pain | 12/26 | 12/27 | | |
NCT05469243: Psychedelic Therapy for Wellness Studies Retrospectively |
|
|
| Active, not recruiting | N/A | 100 | Canada | Psychedelic | Canadian Forces Health Services Centre Ottawa | Well Aging | 08/25 | 08/25 | | |
PREVENT-HCV, NCT05653232: Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients |
|
|
| Recruiting | N/A | 120 | US | Prophylaxis (P2W), Transmit and Treat (T&T) | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) | HCV | 09/25 | 03/27 | | |
| Recruiting | N/A | 40000 | Europe, Canada, Japan, US, RoW | Stroke/Thrombectomy/Aneurysm-specific surgical procedures | Medical University of South Carolina | Stroke, Thromboses, Intracranial, Aneurysm, Brain | 01/55 | 01/55 | | |
| Dęborska-Materkowska, Dominika |
| Recruiting | N/A | 300 | Europe, Canada, US, RoW | MMDx, Prospera, transplant patient blood sample, HLA antibody | University of Alberta, Natera, Inc., One Lambda | Kidney Transplant Rejection | 12/25 | 12/26 | | |
| Ciszek, Michał |
| Recruiting | N/A | 300 | Europe, Canada, US, RoW | MMDx, Prospera, transplant patient blood sample, HLA antibody | University of Alberta, Natera, Inc., One Lambda | Kidney Transplant Rejection | 12/25 | 12/26 | | |
